Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OBLN

Obalon Therapeutics (OBLN) Stock Price, News & Analysis

Obalon Therapeutics logo

About Obalon Therapeutics Stock (NASDAQ:OBLN)

Advanced Chart

Key Stats

Today's Range
$11.16
$12.00
50-Day Range
$2.36
$7.64
52-Week Range
$0.66
$10.77
Volume
28,798 shs
Average Volume
7.68 million shs
Market Capitalization
$113.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OBLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Obalon Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OBLN Stock News Headlines

InterWest Management Partners X, LLC's Net Worth
Obalon Therapeutics, Inc.
“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.tc pixel
Spero Therapeutics Inc.
Renovare Environmental Inc (RENO)
See More Headlines

OBLN Stock Analysis - Frequently Asked Questions

Obalon Therapeutics, Inc. (NASDAQ:OBLN) released its earnings results on Thursday, March, 11th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.06) by $0.11. The company had revenue of $0.06 million for the quarter. Obalon Therapeutics had a negative net margin of 776.76% and a negative trailing twelve-month return on equity of 161.38%.

Obalon Therapeutics shares reverse split on the morning of Thursday, July 25th 2019.The 1-10 reverse split was announced on Wednesday, July 24th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 24th 2019. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Obalon Therapeutics (OBLN) raised $75 million in an initial public offering (IPO) on Thursday, October 6th 2016. The company issued 5,000,000 shares at $14.00-$16.00 per share. UBS Investment Bank, Canaccord Genuity and Stifel served as the underwriters for the IPO and BTIG was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Obalon Therapeutics investors own include Inovio Pharmaceuticals (INO), Vaxart (VXRT), Canopy Growth (CGC), Plug Power (PLUG), NIO (NIO), NVIDIA (NVDA) and OPKO Health (OPK).

Company Calendar

Last Earnings
3/11/2021
Today
8/26/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:OBLN
CIK
1427570
Fax
N/A
Employees
2
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.33 million
Net Margins
-776.76%
Pretax Margin
N/A
Return on Equity
-161.38%
Return on Assets
-83.58%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.86
Quick Ratio
1.86

Sales & Book Value

Annual Sales
$1.59 million
Price / Sales
71.10
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.60 per share
Price / Book
18.80

Miscellaneous

Outstanding Shares
10,022,000
Free Float
N/A
Market Cap
$113.05 million
Optionable
Not Optionable
Beta
-1.23

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:OBLN) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners